Seed · Biotech
Lys Therapeutics: Seed
Develops monoclonal antibody LYS241 targeting neurovascular pathways for Parkinson's disease and stroke
Funding history
Seed · This round>€25M
Loading rounds…
Develops monoclonal antibody LYS241 targeting neurovascular pathways for Parkinson's disease and stroke